Month: April 2023

Global Intelligent Vending Machine Market Size Worth USD 22.0 Billion, Globally, by 2029 at a CAGR of 16.7%

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

The global grinding machines market size is projected to reach USD 22.0 billion in 2029, at compound annual growth rate (CAGR) of 16.7% during the forecast period. The global intelligent vending machine industry was valued at USD 6.51 billion in 2021. Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global intelligent vending machine market size was valued at USD 6.51 billion in 2021 and USD 7.44 billion in 2022. The market is expected to reach USD 22.0 billion by 2029 with a CAGR of 16.7% during the forecast period. Unique user experience created using such machines is expected to propel the market course in a growing direction. Integration of the Internet of Things (IoT) and technological advancements are expected to facilitate market development for intelligent vending machines. Fortune Business Insights™ shares this...

US Blood Glucose Monitoring System Market Size Worth USD 12.94 billion by 2030, exhibiting 9.6% CAGR

Written by Customer Service on April 3, 2023. Posted in Mergers And Acquisitions.

As per the report by Fortune Business Insights, the global US Blood Glucose Monitoring System Market size is projected to reach USD 12.94 billion in 2030, at a CAGR of 9.6% during the forecast period, 2023-2030 Pune, India, April 03, 2023 (GLOBE NEWSWIRE) — The global US Blood Glucose Monitoring System Market was estimated at USD 6.26 billion in 2022. The market valuation is slated to rise from USD 6.82 billion in 2023 to USD 12.94 billion by 2030 at a 9.6% CAGR during the forecast period. Medical equipment called a blood glucose monitoring system is used to keep track of people’s blood glucose levels, particularly those with type 1 and type 2 diabetes. These tools can quickly and accurately measure blood glucose levels, allowing medical decisions to be based on the blood sugar level. Industry Development: February 2022 Senseonics...

MCI Onehealth Reports Fiscal 2022 Financial Results and Announces Review of Strategic Alternatives

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 03, 2023 (GLOBE NEWSWIRE) — MCI Onehealth Technologies Inc. (“MCI” or the “Company”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, has released its financial results for the financial year ended December 31, 2022 and announced that it is engaged in a review of strategic alternatives available to the Company. A summary of MCI’s financial and operational results is set out below, and more detailed information is contained in the financial statements and related management discussion and analysis, which are available on MCI’s SEDAR page at www.sedar.com. Financial measures described as “Adjusted” in this news release are non-IFRS financial measures and may not...

Eloxx Pharmaceuticals Reports Fourth Quarter 2022 Financial and Operating Results and Provides Business Update

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

Three patients now dosed in Phase 2 clinical study evaluating ELX-02 for the treatment of Alport syndrome; encouraging initial reduction in proteinuria has been observed in one patient to date Investigational New Drug (IND) application for ZKN-013 filed for treatment of recessive dystrophic epidermolysis bullosa (RDEB) WATERTOWN, Mass., April 03, 2023 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended December 31, 2022 and provided a business update. “With topline data expected for ELX-02 in Alport syndrome in the first half of 2023, we believe we are approaching a significant milestone for the company, to advance into our first Phase 3 study, with the potential to create significant...

Vaccinex Reports 2022 Financial Results and Provides Corporate Update of Continued Progress in Neurology and Oncology Clinical Programs

Written by Customer Service on April 3, 2023. Posted in Earnings Releases And Operating Results.

Expect to complete patient enrollment in the randomized Phase 1/2a SIGNAL-AD Alzheimer’s study in April 2023 with topline data anticipated mid-2024 Completed enrollment of 36 patients required for a pre-planned interim analysis of KEYNOTE B84 phase 1b/2 study in Head and Neck Squamous Cell Carcinoma ROCHESTER, N.Y., April 03, 2023 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D today announced financial results for the fourth quarter ended December 31, 2022 and provided a corporate update on key programs. In 2022 and continuing in Q1 2023, Vaccinex has made important clinical progress in its major neurology and oncology programs. This month the company will complete enrollment...

One Duck Creek Summit to celebrate its efforts across connection, culture and community

Written by Customer Service on April 3, 2023. Posted in Public Companies.

Boston, April 03, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, will host the One Duck Creek Summit, April 4-6, 2023, in Boston, Massachusetts, bringing leaders together to focus on connection, culture and community. The global attendees are credited for leading the various critical initiatives and programs that make Duck Creek a culture champion in the insurance and technology industries. The diverse collection of people in attendance will spend their time together reflecting on past initiatives and planning future endeavors and setting goals to continue building upon the award-winning culture at Duck Creek. The One Duck Creek Summit will be kicked off by CEO Mike Jackowski, who will emphasize the significance of...

Clever Leaves to Present at Sequire Cannabis & Psychedelics Conference on April 5, 2023 at 2:30 p.m. ET

Written by Customer Service on April 3, 2023. Posted in Public Companies.

TOCANCIPÁ, Colombia, April 03, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that it will be presenting virtually at the upcoming Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, at 2:30 p.m. Eastern time. Event: Clever Leaves Presentation at the Sequire Cannabis & Psychedelics ConferenceDate: Wednesday, April 5, 2023Time: 2:30 p.m. Eastern time Register to watch here: https://cannabis.sequireevents.com/ To receive additional information, please contact your Sequire representative or the Company’s investor relations team at CLVR@gatewayir.com. Summary of Sequire Cannabis & Psychedelics Conference The cannabis and psychedelic...

Navitas and realme Launched World’s First 240W Ultra-Fast Charging Phone at MWC

Written by Customer Service on April 3, 2023. Posted in Public Companies.

Next-gen gallium nitride (GaN) drives ‘Speed to the Max’ SUPERVOOC milestone, with 100% charge in under ten minutesNavitas and realme Launched World’s First 240W Ultra-Fast Charging Phone at MWC Next-gen gallium nitride (GaN) drives ‘Speed to the Max’ SUPERVOOC milestone, with 100% charge in under ten minutesTORRANCE, Calif., April 03, 2023 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company, has announced that its next-generation GaNFast™ technology has been adopted for the ‘in-box’ 240 W ultra-fast charger provided with the recently-announced realme GT3 smartphone. Launched at this year’s Mobile World Conference (MWC), realme’s GT3 is a powerful and stylish new Android device and the world’s first smartphone to offer the power of 240 W charging....

Panbela Announces New Research Agreement with Johns Hopkins University School of Medicine

Written by Customer Service on April 3, 2023. Posted in Public Companies.

MINNEAPOLIS, April 03, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced a new research agreement with the Johns Hopkins University School of Medicine. The collaboration is intended to expand the development of Panbela’s investigative agent ivospemin (SBP-101), including activity in models of ovarian and other cancer types, further evaluations into mechanism of action, and potential combination with CPP-1X and standard of care agents. The research will be co-led by Robert Casero, Ph.D., professor, and Tracy Murray Stewart, Ph.D., Senior Research Scientist, both in oncology at Johns Hopkins University School of Medicine. Prof. Casero and Dr. Murray Stewart are internationally recognized...

HBT Financial, Inc. Announces Executive Officer Transition Plans

Written by Customer Service on April 3, 2023. Posted in Public Companies.

BLOOMINGTON, Ill., April 03, 2023 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT”), the holding company for Heartland Bank and Trust Company (“Heartland Bank”), today announced that Fred L. Drake, Chairman and CEO of the Company and Chairman of Heartland Bank, will transition to the newly created role of Executive Chairman of the Company and Heartland Bank effective May 24, 2023. At that time, J. Lance Carter, President and Chief Operating Officer of the Company and Heartland Bank, will assume the role of President and CEO of the Company and Heartland Bank. Fred Drake stated, “I am very pleased to have Lance Carter assume responsibility as CEO of HBT Financial and Heartland Bank. In recent years, Lance has demonstrated the capability to lead HBT into the future. Over his 22-year career with us, he...

Month: April 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals